Search for other papers by Caroline Y Hayashi in
Google Scholar
PubMed
Search for other papers by Danilo T A Jaune in
Google Scholar
PubMed
Search for other papers by Cristiano C Oliveira in
Google Scholar
PubMed
Search for other papers by Bárbara P Coelho in
Google Scholar
PubMed
Search for other papers by Hélio A Miot in
Google Scholar
PubMed
Search for other papers by Mariângela E A Marques in
Google Scholar
PubMed
Search for other papers by José Vicente Tagliarini in
Google Scholar
PubMed
Search for other papers by Emanuel C Castilho in
Google Scholar
PubMed
Search for other papers by Carlos S P Soares in
Google Scholar
PubMed
Search for other papers by Flávia R K Oliveira in
Google Scholar
PubMed
Cancer Signaling and Metabolism Group, Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Department of Pathology, Medical Faculty of the University of Porto, Porto, Portugal
Search for other papers by Paula Soares in
Google Scholar
PubMed
Search for other papers by Gláucia M F S Mazeto in
Google Scholar
PubMed
Introduction Thyroid cancer is the commonest endocrine neoplasia and its frequency is increasing ( 1 ). The method of choice for diagnosing these lesions is fine-needle aspiration (FNA), with cytological analysis performed using the Bethesda
Search for other papers by Klaudia Zajkowska in
Google Scholar
PubMed
Search for other papers by Janusz Kopczyński in
Google Scholar
PubMed
Search for other papers by Stanisław Góźdź in
Google Scholar
PubMed
Faculty of Health Sciences, Jan Kochanowski University, Kielce, Poland
Search for other papers by Aldona Kowalska in
Google Scholar
PubMed
clinical practice (lower resection rates in patients with indeterminate thyroid cytologies) ( 25 ). Prevalence of NIFTP in PTC in selected Western European and American studies compared to Asian studies is presented in Table 1 . Table 1 Prevalence
Search for other papers by Olav Inge Håskjold in
Google Scholar
PubMed
Search for other papers by Henrik Stenestø Foshaug in
Google Scholar
PubMed
Search for other papers by Therese Benedikte Iversen in
Google Scholar
PubMed
Search for other papers by Helga Charlotte Kjøren in
Google Scholar
PubMed
UiT – The Arctic University of Norway, Institute of Clinical Medicine
Search for other papers by Vegard Heimly Brun in
Google Scholar
PubMed
Introduction Surgery of the thyroid gland can be indicated because of compression symptoms, thyrotoxicosis, or cancer. However, typically 35–40% of surgeries in Europe are made when examination including fine-needle cytology (FNC) biopsy fail
Search for other papers by Elizabeth J de Koster in
Google Scholar
PubMed
Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands
Division of Clinical Studies, Institute of Cancer Research, London, UK
Search for other papers by Olga Husson in
Google Scholar
PubMed
Search for other papers by Eveline W C M van Dam in
Google Scholar
PubMed
Search for other papers by G Sophie Mijnhout in
Google Scholar
PubMed
Search for other papers by Romana T Netea-Maier in
Google Scholar
PubMed
Department of Radiology and Nuclear Medicine, Rijnstate Hospital, Arnhem, The Netherlands
Department of Biomedical Sciences and Humanitas Clinical and Research Centre, Department of Nuclear Medicine, Humanitas University, Milan, Italy
Search for other papers by Wim J G Oyen in
Google Scholar
PubMed
Search for other papers by Marieke Snel in
Google Scholar
PubMed
Department of Radiology, Section of Nuclear Medicine, Leiden University Medical Center, Leiden, The Netherlands
Biomedical Photonic Imaging Group, University of Twente, Enschede, The Netherlands
Search for other papers by Lioe-Fee de Geus-Oei in
Google Scholar
PubMed
Search for other papers by Dennis Vriens in
Google Scholar
PubMed
Search for other papers by for the EfFECTS trial study group in
Google Scholar
PubMed
% of the general population ( 1 , 2 ). Ultrasound and fine-needle aspiration cytology (FNAC) are the first steps in the diagnostic workup ( 3 ). Approximately 25% of cytology results are indeterminate, including atypia of undetermined significance or
Search for other papers by Ayana Suzuki in
Google Scholar
PubMed
Search for other papers by Mitsuyoshi Hirokawa in
Google Scholar
PubMed
Search for other papers by Izumi Otsuka in
Google Scholar
PubMed
Search for other papers by Akihiro Miya in
Google Scholar
PubMed
Search for other papers by Akira Miyauchi in
Google Scholar
PubMed
Search for other papers by Takashi Akamizu in
Google Scholar
PubMed
solid area (a–c), and the whole tumor (d–f) in the three directions were measured. The following findings were obtained from the electronic medical records: age, sex, ultrasound and cytology reports, and postoperative course. The cytology
Search for other papers by Erik Rösner in
Google Scholar
PubMed
Search for other papers by Daniel Kaemmerer in
Google Scholar
PubMed
Search for other papers by Elisa Neubauer in
Google Scholar
PubMed
Search for other papers by Jörg Sänger in
Google Scholar
PubMed
Search for other papers by Amelie Lupp in
Google Scholar
PubMed
for 21 samples. The vast majority of the main study samples were resected specimens, but also 15 biopsies were included. All samples for the pilot and main studies were provided by the Institute of Pathology and Cytology Bad Berka, Bad Berka, Germany
Search for other papers by Dongyan Han in
Google Scholar
PubMed
Search for other papers by Min Ding in
Google Scholar
PubMed
Search for other papers by Rongli Xie in
Google Scholar
PubMed
Shanghai Center of Thyroid Diseases, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, China
Search for other papers by Zhengshi Wang in
Google Scholar
PubMed
Search for other papers by Guohui Xiao in
Google Scholar
PubMed
Search for other papers by Xiaohong Wang in
Google Scholar
PubMed
Search for other papers by Lei Dong in
Google Scholar
PubMed
Shanghai Center of Thyroid Diseases, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, China
Search for other papers by Zhiqiang Yin in
Google Scholar
PubMed
Research Institute of Pancreatic Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai, China
State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Shanghai Jiao Tong University, Shanghai, China
Institute of Translational Medicine, Shanghai Jiao Tong University, Shanghai, China
Search for other papers by Jian Fei in
Google Scholar
PubMed
–24% of FNABs cannot be diagnosed definitively ( 7 ). Still, cytology alone is only a snapshot of the nodule cells at a precise point in time and cannot predict the evolution of the nodule. Next-generation sequencing (NGS) provides diagnostic assistance
Search for other papers by Yosep Chong in
Google Scholar
PubMed
Search for other papers by Soon-Jin Ji in
Google Scholar
PubMed
Search for other papers by Chang Suk Kang in
Google Scholar
PubMed
Search for other papers by Eun Jung Lee in
Google Scholar
PubMed
Introduction Conventional smear (CS) using fine-needle aspiration cytology (FNAC) has been well established during the last few decades as the diagnostic test of choice for making initial diagnosis and treatment plans for thyroid lesions ( 1
Search for other papers by Irfan Vardarli in
Google Scholar
PubMed
Search for other papers by Susanne Tan in
Google Scholar
PubMed
Search for other papers by Rainer Görges in
Google Scholar
PubMed
Search for other papers by Bernhard K Krämer in
Google Scholar
PubMed
Search for other papers by Ken Herrmann in
Google Scholar
PubMed
Search for other papers by Christoph Brochhausen in
Google Scholar
PubMed
, there is a need to avoid unnecessary thyroid surgery. The guidelines recommend the use of molecular tests for further management of thyroid nodules with indeterminate cytology (ITN); however, for the choice of the suitable method and the interpretation
Search for other papers by Adrian F Daly in
Google Scholar
PubMed
Search for other papers by Liliya Rostomyan in
Google Scholar
PubMed
Search for other papers by Daniela Betea in
Google Scholar
PubMed
Search for other papers by Jean-François Bonneville in
Google Scholar
PubMed
Department of Pathological Cytology and Anatomy, Foch Hospital, Paris, France
Search for other papers by Chiara Villa in
Google Scholar
PubMed
Search for other papers by Natalia S Pellegata in
Google Scholar
PubMed
Search for other papers by Beatrice Waser in
Google Scholar
PubMed
Search for other papers by Jean-Claude Reubi in
Google Scholar
PubMed
Search for other papers by Catherine Waeber Stephan in
Google Scholar
PubMed
Search for other papers by Emanuel Christ in
Google Scholar
PubMed
Search for other papers by Albert Beckers in
Google Scholar
PubMed
Acromegaly is a rare disease due to chronic excess growth hormone (GH) and IGF-1. Aryl hydrocarbon receptor interacting protein (AIP) mutations are associated with an aggressive, inheritable form of acromegaly that responds poorly to SST2-specific somatostatin analogs (SSA). The role of pasireotide, an SSA with affinity for multiple SSTs, in patients with AIP mutations has not been reported. We studied two AIP mutation positive acromegaly patients with early-onset, invasive macroadenomas and inoperable residues after neurosurgery. Patient 1 came from a FIPA kindred and had uncontrolled GH/IGF-1 throughout 10 years of octreotide/lanreotide treatment. When switched to pasireotide LAR, he rapidly experienced hormonal control which was associated with marked regression of his tumor residue. Pasireotide LAR was stopped after >10 years due to low IGF-1 and he maintained hormonal control without tumor regrowth for >18 months off pasireotide LAR. Patient 2 had a pituitary adenoma diagnosed when aged 17 that was not cured by surgery. Chronic pasireotide LAR therapy produced hormonal control and marked tumor shrinkage but control was lost when switched to octreotide. Tumor immunohistochemistry showed absent AIP and SST2 staining and positive SST5. Her AIP mutation positive sister developed a 2.5 cm follicular thyroid carcinoma aged 21 with tumoral loss of heterozygosity at the AIP locus and absent AIP staining. Patients 1 and 2 required multi-modal therapy to control diabetes. On stopping pasireotide LAR after >10 years of treatment, Patient 1’s glucose metabolism returned to baseline levels. Long-term pasireotide LAR therapy can be beneficial in some AIP mutation positive acromegaly patients that are resistant to first-generation SSA.